Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

AQST Stock Forecast, Price Targets, Chart, Dividends & Analysis

Aquestive Therapeutics Inc. logo

Aquestive Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

3.65
 
USD
  
0.01
  
(0.27%)
Previous close: 3.64  Open: 3.56  Bid: 3.64  Ask: 3.69
52 week range    
1.95   
   6.23
Mkt Cap: 351 M  Avg Vol (90 Days): 1,622,625
Peers   
OMHE / 
OILS-CA / 
OGN / 
Last updated: Sunday 22nd December 2024

Stock Rankings

31
MarketXLS Rank
40
Value
15
Technical
39
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

OGN

0.07684 B2.8914.58

OILS-CA

OMHE

ONPH

Financials

AQST Income Statement

Annual
Invalid dateDec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles-50000.0-50000.051000.051000.0116000.0157000.0
Basic EPS from continuing operations-1.85-1.12-0.13
Basic EPS total-1.85-1.12-0.13
Basic weighted shares outstanding21 M25 M34 M38 M49 M61 M
Cost of sales-20 M-13 M15 M19 M21 M
Depreciation-3 M-3 M3 M3 M2 M1 M
Depreciation unreconciled2 M
DepreciationAndAmortization-3 M-3 M3 M3 M2 M1 M
Diluted EPS total-2.96-2.61-1.66-1.85-1.12-0.13
Diluted normalized net income/share-1.85-1.12-0.13
Diluted weighted shares outstanding21 M25 M34 M38 M49 M61 M
GeneralAndAdministrativeExpense-1 M-2 M56 M53 M53 M32 M
Gross operating profit67 M32 M46 M36 M28 M30 M
Income before tax-61 M-66 M-56 M-71 M-54 M-8 M
Income restructuring and M&A-130000.0-144000.0-165000.0
Income taxes245000.0
Interest income552000.0636000.0132000.0423000.099000.0
InterestExpenseNonOperating8 M9 M13 M22 M12 M7 M
MiscOtherSpecialCharges-5 M-5 M-165000.0-14 M-1 M
Net income from total operations-61 M-66 M-56 M-71 M-54 M-8 M
NetIncomeCommonStockholders-61 M-66 M-28 M-71 M-54 M-8 M
NetIncomeContinuousOperations-61 M-66 M-56 M-71 M-54 M-8 M
NetNonOperatingInterestIncomeExpense-7 M-9 M-11 M-10 M12 M-9 M
Normalized income-6 M
Operating income-49 M-53 M-43 M-35 M-42 M-15 M
Operating income before depreciation (EBITDA)-49 M-52 M-39 M-45 M-40 M1 M
OperatingExpense-116 M85 M89 M86 M70 M45 M
Other income net5 M5 M447000.014 M-1 M
OtherGandA-1 M-2 M56 M53 M53 M32 M
OtherImpairmentOfCapitalAssets216000.0
OtherOperatingExpenses21 M-66000.0-13 M-15 M2 M905000.0
OtherWriteOff-50000.0282000.0
RentAndLandingFees-1 M-2 M
Research & development expense23 M21 M20 M17 M17 M13 M
ResearchExpense23 M21 M20 M17 M17 M13 M
RestructringAndMnAIncome-130000.0-144000.0-165000.0
Revenue per share-2 M-2 M51000.051000.0331000.02 M
SalariesAndWages-30 M-7 M-7 M
Selling Gen & administrative expense72 M64 M56 M53 M53 M32 M
SellingAndMarketingExpense72 M64 M56 M
SellingExpense72 M64 M56 M
Special income/charges130000.0144000.0165000.0
Total Income available for interest expense (EBIT)-54 M-57 M-43 M-48 M-42 M-163000.0
Total common shares outstanding25 M34 M36 M41 M56 M73 M
Total net income-61 M-66 M-56 M-71 M-54 M-8 M
Total ordinary shares91 M91 M91 M91 M91 M91 M
Total revenues67 M53 M46 M51 M48 M51 M
TotalExpenses-116 M65 M65 M86 M90 M66 M
TotalRevenue67 M53 M46 M51 M48 M51 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University